in postPLTPLTRSHORTFIRST CALL

“England's health service has acknowledged that some of its main claims about the benefits of Palantir's software are not causationally robust, leading to calls ”

NHS England admits Palantir's headline NHS benefits are not causally proven, putting the £330M contract at risk and stripping the government-contract growth narrative.

PLTPLTRSHORT@ $115.49

$124.83-8.09%

since call Jun 25

Trade on Hyperliquid →